Literature DB >> 33583450

Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.

Ya Gao1,2, Yamin Chen1,2, Ming Liu1,2, Mingming Niu1,2, Ziwei Song1,2, Meili Yan1,2, Jinhui Tian1,3.   

Abstract

Coronavirus disease 2019 (COVID-19) has become a global pandemic. Previous studies showed that comorbidities in patients with COVID-19 are risk factors for adverse outcomes. This study aimed to clarify the association between nervous system diseases and severity or mortality in patients with COVID-19. We performed a systematic literature search of four electronic databases and included studies reporting the prevalence of nervous system diseases in COVID-19 patients with severe and non-severe disease or among survivors and non-survivors. The included studies were pooled into a meta-analysis to calculate the odds ratio (OR) with 95% confidence intervals (95%CI). We included 69 studies involving 17 879 patients. The nervous system diseases were associated with COVID-19 severity (OR = 3.19, 95%CI: 2.37 to 4.30, P < 0.001) and mortality (OR = 3.75, 95%CI: 2.68 to 5.25, P < 0.001). Specifically, compared with the patients without cerebrovascular disease, patients with cerebrovascular disease infected with COVID-19 had a higher risk of severity (OR = 3.10, 95%CI: 2.21 to 4.36, P < 0.001) and mortality (OR = 3.45, 95% CI: 2.46 to 4.84, P < 0.001). Stroke was associated with severe COVID-19 disease (OR = 1.95, 95%CI: 1.11 to 3.42, P = 0.020). No significant differences were found for the prevalence of epilepsy (OR = 1.00, 95%CI: 0.42 to 2.35, P = 0.994) and dementia (OR = 2.39, 95%CI: 0.55 to 10.48, P = 0.247) between non-severe and severe COVID-19 patients. There was no significant association between stroke (OR = 1.79, 95%CI: 0.76 to 4.23, P = 0.185), epilepsy (OR = 2.08, 95%CI: 0.08 to 50.91, P = 0.654) and COVID-19 mortality. In conclusion, nervous system diseases and cerebrovascular disease were associated with severity and mortality of patients with COVID-19. There might be confounding factors that influence the relationship between nervous system diseases and COVID-19 severity as well as mortality.

Entities:  

Keywords:  COVID-19; Cerebrovascular disease; meta-analysis; mortality; nervous system disease; severe illness

Year:  2021        PMID: 33583450     DOI: 10.1017/S0950268821000376

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  8 in total

Review 1.  Animal models for COVID-19: advances, gaps and perspectives.

Authors:  Changfa Fan; Yong Wu; Xiong Rui; Yuansong Yang; Chen Ling; Susu Liu; Shunan Liu; Youchun Wang
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

Review 2.  Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence.

Authors:  Marina Treskova-Schwarzbach; Laura Haas; Sarah Reda; Antonia Pilic; Anna Borodova; Kasra Karimi; Judith Koch; Teresa Nygren; Stefan Scholz; Viktoria Schönfeld; Sabine Vygen-Bonnet; Ole Wichmann; Thomas Harder
Journal:  BMC Med       Date:  2021-08-27       Impact factor: 8.775

3.  Immunological alternation in COVID-19 patients with cancer and its implications on mortality.

Authors:  Guangyao Cai; Yue Gao; Shaoqing Zeng; Yang Yu; Xingyu Liu; Dan Liu; Ya Wang; Ruidi Yu; Aakash Desai; Chunrui Li; Qinglei Gao
Journal:  Oncoimmunology       Date:  2021-01-04       Impact factor: 8.110

4.  COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paper.

Authors:  Martin Rakusa; Serefnur Öztürk; Elena Moro; Raimund Helbok; Claudio L Bassetti; Ettore Beghi; Daniel Bereczki; Benedetta Bodini; Giovanni Di Liberto; Thomas M Jenkins; Antonella Macerollo; Luis F Maia; Filippo Martinelli-Boneschi; Antonio Pisani; Alberto Priori; Anna Sauerbier; Riccardo Soffietti; Pille Taba; Tim J von Oertzen; Marialuisa Zedde; Michael Crean; Anja Burlica; Francesco Cavallieri; Johann Sellner
Journal:  Eur J Neurol       Date:  2022-05-10       Impact factor: 6.288

5.  Association Between Previous Stroke and Severe COVID-19: A Retrospective Cohort Study and an Overall Review of Meta-Analysis.

Authors:  Huayao Huang; Junnian Chen; Shuangfang Fang; Xiaoling Chen; Xiaobin Pan; Hanhan Lei; Yixian Zhang; Hailong Lin; Qilin Yuan; Pincang Xia; Nan Liu; Houwei Du
Journal:  Front Neurol       Date:  2022-07-12       Impact factor: 4.086

6.  Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: A systematic review and meta-analysis.

Authors:  Zhe Chen; Yingying Peng; Xiaolei Wu; Bo Pang; Fengwen Yang; Wenke Zheng; Chunxiang Liu; Junhua Zhang
Journal:  Front Public Health       Date:  2022-08-16

7.  Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants.

Authors:  Ludi Yang; Peiwei Chai; Jie Yu; Xianqun Fan
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

Review 8.  The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates.

Authors:  Shuwen Li; Jiahao Ren; Hongjie Hou; Xueya Han; Jie Xu; Guangcai Duan; Yadong Wang; Haiyan Yang
Journal:  Neurol Sci       Date:  2022-03-24       Impact factor: 3.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.